Fibrogen Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Fibrogen Contact Number

Contact Email [email protected] Phone Number 415-978-1200 FibroGen is a research-based biotechnology company using its expertise in …

Contact US: https://www.crunchbase.com/organization/fibrogen

Where are the headquarters of fibrogen inc?

About us. FibroGen, Inc., headquartered in San Francisco, with subsidiary offices in Beijing and Shanghai, is a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics.

What kind of rare disease does fibrogen have?

FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

Why is international womens day important for fibrogen?

This International Women’s Day, FibroGen is inspired by its female employees who have dedicated themselves to advancing groundbreaking innovation that has transformed patient care. #IWD2021 Today FibroGen announced our Q4 and full year 2020 financial results.

Insights

108 People Used

See More ››

Fibrogen, Inc. Company Profile San Francisco, CA

Find company research, competitor information, contact details & financial data for Fibrogen, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.

View Contact ››

Contact

47 People Used

See More ››

Fibrogen San Francisco CA, 94158 – Manta.com

Contact. Fibrogen Inc; 409 Illinois Street; San Francisco, CA 94158 (415) 978-1433 Get Directions Similar Businesses. Detailed Information. Location Type Single Location; Year Established 1993; Annual Revenue Estimate $50 to 100 million

View Contact ››

Fibrogen

86 People Used

See More ››

Fibrogen, Inc.

Fibrogen, Inc. was founded in 1993, and is located at 409 Illinois St in San Francisco. Additional information is available at www.fibrogen.com or by contacting Thomas B Neff at (415) 978-1200.

View Contact ››

Francisco

62 People Used

See More ››

Fibrogen Inc in San Francisco, CA with Reviews

(415) 978-1200 409 Illinois St San Francisco, CA 94158 From Business: Located in San Francisco, Calif., FibroGen Inc. is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and…

View Contact ››

Confirmation

122 People Used

See More ››

FibroGen Provides Additional Information on Roxadustat

Confirmation number: 5297733 A replay of the webcast and investor presentation will be available shortly after the call for a period of 30 days. To access the replay, please dial (855) 859-2056 (domestic) or (404) 537-3406 (international), and use passcode 5297733. About Anemia of CKD

View Contact ››

·

61 People Used

See More ››

FibroGen, Inc.

FibroGen, Inc., San Francisco, California. 189 likes · 5 talking about this · 229 were here. FibroGen was founded to discover, develop, and commercialize novel therapeutics that stop fibrosis, or

View Contact ››

Global

53 People Used

See More ››

FGEN

SAN FRANCISCO, July 12, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) announced the appointment of John Hunter, Ph.D., to the position of Chief Scientific Officer, where he will lead FibroGen''s research efforts, leveraging more than 20 years of global biopharmaceutical leadership and experience. "Great science and innovation are the backbone of FibroGen

View Contact ››

FibroGen

34 People Used

See More ››

FibroGen Company Profile

FibroGen has 531 employees at their 1 location and $176.32 M in annual revenue in FY 2020. See insights on FibroGen including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

View Contact ››

E-mail

72 People Used

See More ››

E mail Alerts FibroGen, Inc.

E-mail Alerts. You may automatically receive FibroGen Inc financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit.

View Contact ››

Company

40 People Used

See More ››

Investor Overview FibroGen, Inc.

FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer.

View Contact ››

Informa

162 People Used

See More ››

FibroGen’s Roxadustat Faces US FDA Scrutiny On ‘Prominent

Informa UK Limited is a company registered in England and Wales with company number 1072954 whose registered office is 5 Howick Place, London, SW1P 1WG. Informa UK Limited is a …

View Contact ››

About

173 People Used

See More ››

(FGEN) Alert: Did You Lose Money on Your FibroGen

If you have information that could assist in this investigation, including past employees and others, or if you are a FibroGen shareholder and are interested in learning more about the

View Contact ››

FibroGen

117 People Used

See More ››

FibroGen, Inc. LinkedIn

FibroGen, Inc.

View Contact ››

Revenue

62 People Used

See More ››

FibroGen Company Profile: Stock Performance & Earnings

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen''s revenue to date has been generated from its collaboration agreements.

View Contact ››

FibroGen''s

91 People Used

See More ››

FibroGen''s (FGEN) Cardiovascular Data Mess Seeking Alpha

FibroGen''s Cardiovascular Data Mess. Avisol Capital Partners runs the Total Pharma Tracker Seeking Alpha Marketplace service. This is managed by Dr Asok Dutta, BVScAH and Dr Udaya Kumar Maiya, MD

View Contact ››

FibroGen

61 People Used

See More ››

FibroGen, Inc (FGEN) Company Profile & Facts

FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California. Corporate Governance FibroGen, Inc.’s ISS Governance QualityScore as of July 1, 2021 is 7.

View Contact ››

Google

60 People Used

See More ››

Google Account Help

Official Google Account Help Center where you can find tips and tutorials on using Google Account and other answers to frequently asked questions.

View Contact ››

Employees

94 People Used

See More ››

FibroGen Number of Employees 2013 2021 FGEN MacroTrends

FibroGen number of employees from 2013 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash …

View Contact ››

Annual

81 People Used

See More ››

FibroGen

Flad worked closely with FibroGen and the local utility company to design a building that incorporated California''s Savings by Design guidelines. The result was an annual savings of approximately $250,000 in energy bills. Location San Francisco, Careers Contact Noteworthy.

View Contact ››

Business

82 People Used

See More ››

Events & Presentations FibroGen, Inc.

The Investor Relations website contains information about FibroGen, Inc.''s business for stockholders, potential investors, and financial analysts.

View Contact ››

Fibrogen’s

67 People Used

See More ››

FibroGen Inc.

FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuring investors.

View Contact ››

Fibrogen

148 People Used

See More ››

FIBROGEN INVESTORS: June 11, 2021 Filing Deadline in Class

Fibrogen investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358. Background on the Fibrogen Securities Class Litigation

View Contact ››

Development

89 People Used

See More ››

FibroGen Headquarters Hathaway Dinwiddie Construction

Contact; FibroGen Headquarters. FibroGen’s Headquarters in San Francisco is the first midrise biotech facility with an L-occupancy to be constructed in California. The 6-story building features research and development laboratories used for drug discovery and development work in biology and chemistry, hazardous materials storage, executive

View Contact ››

Company

83 People Used

See More ››

FGEN FibroGen Inc. Company Profile & Executives

Company profile for FibroGen Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed FGEN description & address.

View Contact ››

Class

112 People Used

See More ››

FGEN Company Profile & Executives

DEADLINE TODAY: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the

View Contact ››

Company

76 People Used

See More ››

FibroGen Inc

Company profile page for FibroGen Inc including stock price, company news, press releases, executives, board members, and contact information

View Contact ››

Factor

101 People Used

See More ››

FIBROGEN, INC. : Shareholders Board Members Managers and

FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines for the treatment of unmet needs.

View Contact ››

Cases

150 People Used

See More ››

Mid Day Market Update: Crude Oil Down 1%; FibroGen Shares

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,977,710 cases with around 608,400 deaths. FibroGen, Inc. Contact us!

View Contact ››

Company

105 People Used

See More ››

Working at FibroGen Glassdoor

Revenue: $100 to $500 million (USD) Competitors: Amgen, Pliant Therapeutics, Akebia Therapeutics. Create Comparison. FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and

View Contact ››

Growing

92 People Used

See More ››

FibroGen Reviews Glassdoor

Innovative and fast growing company. Cons. Under the previous leadership, there seemed to have been so cultural crisis where the negative reviews which are clearly outdated. However, under the new leadership, Fibrogen is growing fast and heading in the right direction. This is the best time to join the organization.

View Contact ››

Mid-Day

141 People Used

See More ››

Mid Day Market Update: Crude oil down 1%, FibroGen shares

Mid-Day Market Update: Crude oil down 1%, FibroGen shares plummet. Midway through trading Friday, the Dow traded down 0.32% to 34,874.67 …

View Contact ››

1015

137 People Used

See More ››

FibroGen Stock Collapses After FDA Panel Rejects Anemia

10:15 AM ET 07/16/2021. A Food and Drug Administration panel voted resoundingly against recommending approval for an anemia treatment from FibroGen ( FGEN ), and FGEN stock tanked on Friday. X

View Contact ››

FibroGen

134 People Used

See More ››

FibroGen Stock Crashes After Backtracking Safety Data For

FibroGen stock crashed to a four-year low Wednesday after backtracking some of the safety data for its anemia treatment in chronic kidney disease patients. Please contact

View Contact ››

Please leave your comments here:

Popular Brands

Ford
Fanuc
Fmc
Fedex
Fluent
Flex